Alex Dahl to Speak on Panel at The Partnership for Safe Medicines Interchange 2011
Alex Dahl will speak on the panel, “Protecting Our Medicines.” He is a member of The Coalition for Patient Safety and Medicine Integrity which is a group of pharmaceutical, medical device and medical products companies focused on patient safety.
Its purpose is to protect patients from the risks posed by stolen and inappropriately handled medical products re-entering the legitimate supply chain. The Coalition includes: Abbott Laboratories, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Novo Nordisk, Sanofi Aventis, and PhRMA.
Alex Dahl will speak on the panel, “Protecting Our Medicines.” He is a member of The Coalition for Patient Safety and Medicine Integrity which is a group of pharmaceutical, medical device and medical products companies focused on patient safety.
Its purpose is to protect patients from the risks posed by stolen and inappropriately handled medical products re-entering the legitimate supply chain. The Coalition includes: Abbott Laboratories, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Novo Nordisk, Sanofi Aventis, and PhRMA.
The Coalition is asking Congress to pass S. 1002, the SAFE DOSES Act, to modernize and strengthen the criminal code in order to deter and punish medical product cargo theft. Current federal criminal laws do not distinguish between stealing a load of insulin and stealing a truck full of televisions – even though the potential harm is vastly greater when medical products are involved. Higher possible sentences will not only make people think twice before acting, but also will provide law enforcement agencies with the tools they need to obtain cooperation in bringing down criminal organizations.
Learn more about how agencies and industry fight medicine counterfeiting and sales at the 2011 Interchange on October 27 at the National Press Club.
